Trial Profile
Polaprezinc in patients with ulcerative colitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Polaprezinc (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 26 Sep 2012 Data incorporated from University Hospital Information Network Japan (UMIN000008967).
- 29 May 2012 New trial record
- 22 May 2012 Results presented at Digestive Disease Week 2012.